CSIMarket
 
Milestone Pharmaceuticals Inc   (NASDAQ: MIST)
 

Milestone Pharmaceuticals Inc's Suppliers Performance

MIST's Supply Chain




 
MIST Costs vs Sales of Suppliers Growth Milestone Pharmaceuticals Inc's cost of sales deteriorated by 0 % year on year, sequentially cost of sales grew by 128.57 % in Q2.

• More on MIST Suppliers



Milestone Pharmaceuticals Inc's cost of sales deteriorated by 0 % year on year, sequentially cost of sales grew by 128.57 % in Q2.

• More on MIST Suppliers




Milestone Pharmaceuticals Inc's Comment on Supply Chain


The company sources raw materials, nasal spray devices, active pharmaceutical ingredients (API), and finished products for commercial products, clinical trials, and preclinical research through contract manufacturing organizations (CMOs). All CMOs are required to comply with current good manufacturing practice (cGMP) standards. The company has contracts and quality agreements with CMOs for the manufacturing of etripamil drug substance and drug product and currently maintains sufficient supply to support commercial launch. It may engage additional CMOs for manufacturing regulatory starting materials, filling nasal spray devices, labeling, packaging, storage, and distribution of investigational and commercial drug products. The company plans to continue relying on third-party manufacturers for future trials and commercialization and expects these CMOs to have the capacity to support commercial-scale production.

Milestone Pharmaceuticals Inc's Comment on Supply Chain


The company sources raw materials, nasal spray devices, active pharmaceutical ingredients (API), and finished products for commercial products, clinical trials, and preclinical research through contract manufacturing organizations (CMOs). All CMOs are required to comply with current good manufacturing practice (cGMP) standards. The company has contracts and quality agreements with CMOs for the manufacturing of etripamil drug substance and drug product and currently maintains sufficient supply to support commercial launch. It may engage additional CMOs for manufacturing regulatory starting materials, filling nasal spray devices, labeling, packaging, storage, and distribution of investigational and commercial drug products. The company plans to continue relying on third-party manufacturers for future trials and commercialization and expects these CMOs to have the capacity to support commercial-scale production.







MIST's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Milestone Pharmaceuticals Inc 98.15 0.00 -84.01 38
SUBTOTAL 0.00 0.00 0.00 -


Sources: Milestone Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Milestone Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.